Securities Lawsuit Filed Against RxSight, Inc.

Allegations of securities fraud have been made against RxSight, Inc. (NASDAQ: RXST) concerning its financial guidance and product demand. The class-action lawsuit seeks to recover losses for shareholders who were allegedly misled by the Company's statements between November 7, 2024, and July 8, 2025. The complaint claims that the Company overstated the demand for its products and failed to disclose "adoption challenges" and structural issues that led to declining sales and utilization.

Key Takeaways:

• The lawsuit alleges that RxSight, Inc. made false statements and concealed the truth about its financial performance and product demand between November 7, 2024, and July 8, 2025.
• The complaint specifically claims that the Company overstated the demand for its products and failed to disclose "adoption challenges" and structural issues that led to declining sales and utilization.
• The lawsuit seeks to recover losses for shareholders who were allegedly misled by the Company's statements.
• The law firm Levi & Korsinsky is representing the plaintiffs in the case and has a track record of securing significant recoveries for aggrieved shareholders.
• The law firm has extensive expertise in representing investors in complex securities litigation and has been recognized as one of the top securities litigation firms in the United States.

Statistics:

• The lawsuit covers the period between November 7, 2024, and July 8, 2025.
• The complaint alleges that RxSight, Inc. overstated the demand for its products during this time.
• Levi & Korsinsky has secured hundreds of millions of dollars for aggrieved shareholders in the past 20 years.
• The law firm has a team of over 70 employees serving clients in complex securities litigation.

Sources:

• https://zlk.com/pslra-1/rxsight-inc-lawsuit-submission-form?prid=163419&wire=5&utm_campaign=3
• https://www.newsfilecorp.com/release/263732